Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 118,444 clinical trials worldwide
Search
Showing 90301-90350 of 118,444 trials
Active filters:
Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting
Clinical Trials (118,444)
NCT05822271
Evaluation of Surgical Outcomes of Patients Treated With the Surgery First Approach and Aligners
NA
Recruiting
20 participants
Started: Jan 30, 2022 · Completed: Oct 31, 2025
1 condition
1 sponsor
1 location
NCT05528380
Development of a Lifestyle Physical Activity Intervention to Reduce Risk for Perinatal Cannabis Use
NA
Recruiting
50 participants
Started: Jan 30, 2022 · Completed: Feb 28, 2026
2 conditions
1 sponsor
1 location
NCT05175417
Visualization of Neural Targets With 3T MRI
N/A
Recruiting
40 participants
Started: Jan 29, 2022 · Completed: Dec 31, 2025
1 condition
1 sponsor
1 location
NCT05171972
Reduced Oligodendrocyte-specific Cytotoxicity and Ofatumumab Treatment
N/A
Active, not recruiting
40 participants
Started: Jan 29, 2022 · Completed: Jun 30, 2025
1 condition
2 sponsors
1 location
NCT05063032
Left Atrial FLUTter: a Comparison of Ablation Guided by High-density MApping and Empirical LINEar Ablation.
NA
Recruiting
100 participants
Started: Jan 28, 2022 · Completed: Oct 1, 2024
1 condition
1 sponsor
1 location
NCT05213806
WithHolding Enteral Feeds Around Blood Transfusion (International)
NA
Recruiting
4,333 participants
Started: Jan 28, 2022 · Completed: Dec 31, 2025
1 condition
3 sponsors
1 location
NCT06329466
The Effect of Emotional Freedom Technique (EFT) on Pain Intensity and Menstruation Symptoms
N/A
Active, not recruiting
48 participants
Started: Jan 28, 2022 · Completed: Jul 25, 2024
1 condition
2 sponsors
1 location
NCT06847295
Epidural Electrical Stimulation to Restore Standing and Walking in Patients With Chronic Paralysis Due to Spinal Cord Injury: A Study on Motor Recovery, Spasticity Reduction, and Quality of Life Improvement Through Neuromodulation and Intensive Rehabilitation
NA
Recruiting
10 participants
Started: Jan 28, 2022 · Completed: Jan 10, 2027
2 conditions
2 sponsors
1 location
NCT06352502
An Observational Study of Furmonertinib for EGFR Mutation-positive NSCLC Patients With Brain Metastasis
N/A
Recruiting
30 participants
Started: Jan 28, 2022 · Completed: Sep 30, 2024
2 conditions
1 sponsor
1 location
NCT05065294
Psilocybin Therapy for Depression in Bipolar II Disorder
PHASE2
Active, not recruiting
14 participants
Started: Jan 28, 2022 · Completed: Jul 31, 2025
1 condition
1 sponsor
1 location
NCT04765098
Tamoxifen Versus Etoposide After First Recurrence in GBM Patients
PHASE2
Recruiting
60 participants
Started: Jan 28, 2022 · Completed: Jul 31, 2027
1 condition
1 sponsor
1 location
NCT04870944
CBL0137 for the Treatment of Relapsed or Refractory Solid Tumors, Including CNS Tumors and Lymphoma
PHASE1/PHASE2
Recruiting
63 participants
Started: Jan 28, 2022 · Completed: Dec 31, 2026
10 conditions
2 sponsors
34 locations
NCT06945731
The Effectiveness of Repetitive Transcranial Magnetic Stimulation for Weight Loss in Overweight and Obese Patients
NA
Active, not recruiting
50 participants
Started: Jan 28, 2022 · Completed: Jun 1, 2026
2 conditions
1 sponsor
1 location
NCT05362903
A Non-interventional Implementation Study to Evaluate Treatment With Inclisiran (Leqvio®) and Other Lipid Lowering Treatments in a Real-world Setting
N/A
Active, not recruiting
1,854 participants
Started: Jan 28, 2022 · Completed: Dec 1, 2025
1 condition
1 sponsor
122 locations
NCT05064865
Impact of Regular Consumption of Grapes on Eye Health in Singapore Older Adults
NA
Active, not recruiting
34 participants
Started: Jan 28, 2022 · Completed: Oct 31, 2024
2 conditions
3 sponsors
1 location
NCT04816773
Post Market Clinical Follow-Up Study for EVOLUTION® NitrX™ Keeled Tibia and EVOLUTION® NitrX™ CS/CR Femur With Cruciate Sacrificing Insert
N/A
Enrolling by invitation
150 participants
Started: Jan 27, 2022 · Completed: Jan 31, 2035
4 conditions
1 sponsor
2 locations
NCT05026632
NPI-002 Intravitreal Implant for the Delay of Cataract Progression
PHASE1/PHASE2
Recruiting
30 participants
Started: Jan 27, 2022 · Completed: Dec 31, 2025
1 condition
1 sponsor
1 location
NCT05139095
Camrelizumab Plus Apatinib in Patients With High-risk Gestational Trophoblastic Neoplasia
PHASE2
Recruiting
70 participants
Started: Jan 27, 2022 · Completed: Jan 1, 2027
1 condition
2 sponsors
1 location
NCT04980833
Study Assessing Long-term Safety and Efficacy of Alpelisib in Patients With PIK3CA-Related Overgrowth Spectrum (PROS) Who Previously Participated in Study CBYL719F12002 (EPIK-P1)
PHASE2
Active, not recruiting
41 participants
Started: Jan 27, 2022 · Completed: Jul 22, 2027
1 condition
1 sponsor
6 locations
NCT05231993
Clinical Triage and Treatment of Atypical Glandular Cells (AGC) Detected in Screening
NA
Enrolling by invitation
280 participants
Started: Jan 27, 2022 · Completed: Dec 31, 2029
1 condition
3 sponsors
1 location
NCT05293366
LOng COvid COmorbidities: Endocrine,Metabolic,Neuropsychiatric,Muscle,Cardiovascular,Pulmonary,Dermatologic Dysfunctions
N/A
Recruiting
100 participants
Started: Jan 27, 2022 · Completed: Jan 27, 2027
1 condition
2 sponsors
1 location
NCT05369065
Ablation of Arteries for the Treatment of Type 2 Diabetes Mellitus and Its Comorbidities
PHASE1
Recruiting
60 participants
Started: Jan 27, 2022 · Completed: Jan 31, 2029
2 conditions
2 sponsors
3 locations
NCT05241392
Safety and Efficacy Study of Anti-B7-H3 CAR-T Cell Therapy for Recurrent Glioblastoma
PHASE1
Active, not recruiting
30 participants
Started: Jan 27, 2022 · Completed: Dec 31, 2026
1 condition
1 sponsor
1 location
NCT05165446
Novel MRE Technique to Assess a Risk Factor for Liver Cancer
N/A
Active, not recruiting
35 participants
Started: Jan 27, 2022 · Completed: Sep 30, 2025
1 condition
1 sponsor
1 location
NCT05898711
Kerecis Case Registry for SurgiBind : Soft Tissue Reinforcement
N/A
Active, not recruiting
200 participants
Started: Jan 27, 2022 · Completed: Jan 27, 2026
1 condition
1 sponsor
1 location
NCT04687215
Diabetic Neuropathy in Spinal Cord Stimulator Patients
N/A
Recruiting
25 participants
Started: Jan 27, 2022 · Completed: Dec 1, 2026
7 conditions
1 sponsor
1 location
NCT05318183
Assessing Gut Microbiota Mediated Health Outcomes of Whole Wheat and Its Major Bioactive Components
NA
Active, not recruiting
65 participants
Started: Jan 27, 2022 · Completed: May 30, 2026
4 conditions
2 sponsors
1 location
NCT05194345
An Integrated Nutrition Intervention to Promote Healthy Eating Habits for Children With ASD
NA
Active, not recruiting
51 participants
Started: Jan 27, 2022 · Completed: May 31, 2024
1 condition
1 sponsor
1 location
NCT04941937
Selinexor in Combination With Immunomodulator (Thalidomide/Pomalidomide/Lenalidomide)in RRMM
PHASE2
Recruiting
90 participants
Started: Jan 27, 2022 · Completed: Dec 30, 2025
1 condition
1 sponsor
1 location
NCT05379556
LOng COvid COmorbidities: Andrological, Reproductive, Sexual Dysfunctions in Patients Recovered From COVID-19
N/A
Recruiting
100 participants
Started: Jan 27, 2022 · Completed: Jan 27, 2027
1 condition
2 sponsors
1 location
NCT04823624
MBG453 in Lower Risk MDS
PHASE2
Active, not recruiting
20 participants
Started: Jan 27, 2022 · Completed: Nov 1, 2026
1 condition
2 sponsors
3 locations
NCT04894188
Neoadjuvant Hormone and Radiation Therapy Followed by Radical Prostatectomy in Patients With High-Risk Prostate Cancer
NA
Recruiting
38 participants
Started: Jan 27, 2022 · Completed: Jul 1, 2041
1 condition
1 sponsor
2 locations
NCT04796220
Focused Ultrasound and Gemcitabine in Breast Cancer
PHASE1
Recruiting
32 participants
Started: Jan 27, 2022 · Completed: Feb 28, 2030
2 conditions
1 sponsor
1 location
NCT06833229
Prospective Cohort Study Evaluating 18FDG PET-CT for the Early Prediction of the Efficacy of Immunotherapy Associated or Not With Chemotherapy in Patients With Locally Advanced or Metastatic Non-Small Cell Broncho-Pulmonary Carcinoma
N/A
Recruiting
200 participants
Started: Jan 27, 2022 · Completed: Jan 27, 2031
1 condition
1 sponsor
1 location
NCT05082961
Circulating Immunes Cells, Cytokines and Brain Radiotherapy
NA
Recruiting
40 participants
Started: Jan 27, 2022 · Completed: Oct 31, 2028
1 condition
4 sponsors
1 location
NCT05156268
A Study of Pembrolizumab and Olaparib in People With Endometrial Cancer or Endometrial Carcinosarcoma
PHASE2
Active, not recruiting
26 participants
Started: Jan 27, 2022 · Completed: Jan 31, 2026
1 condition
2 sponsors
7 locations
NCT05130138
Interest of PHARMaceutical Conciliation to Understand Drug Interactions, Phytotherapy, and Targeted Therapies in Chronic Myeloid Leukemia
NA
Recruiting
100 participants
Started: Jan 27, 2022 · Completed: Nov 1, 2026
1 condition
2 sponsors
1 location
NCT05198804
A Study of ZN-c3 and Niraparib in Subjects With Platinum-Resistant Ovarian Cancer
PHASE1/PHASE2
Active, not recruiting
117 participants
Started: Jan 27, 2022 · Completed: May 31, 2025
4 conditions
1 sponsor
20 locations
NCT05251259
Study to Assess the Efficacy and Safety of Atuliflapon in Moderate-to-Severe Uncontrolled Asthma
PHASE2
Active, not recruiting
622 participants
Started: Jan 27, 2022 · Completed: Jan 29, 2026
1 condition
1 sponsor
267 locations
NCT05016258
"Performance and Safety Use of the Mono Block Implant KONTACT MB"
N/A
Recruiting
159 participants
Started: Jan 26, 2022 · Completed: Oct 31, 2025
4 conditions
1 sponsor
1 location
NCT07062549
Study of 111In-XYIMSR-01 SPECT/CT in Patients With Metastatic Clear Cell Renal Cell
PHASE1
Recruiting
6 participants
Started: Jan 26, 2022 · Completed: Jul 31, 2029
1 condition
1 sponsor
1 location
NCT05338060
A Systems Approach to Immunotherapy Biomarker Identification Within the Postoperative Wound-Healing Microenvironment in Patients With Gastroesophageal Cancer
N/A
Active, not recruiting
10 participants
Started: Jan 26, 2022 · Completed: Jan 30, 2026
1 condition
2 sponsors
1 location
NCT05306561
Evaluating Impact of Systane iLux on Dryness Symptoms and Wearing Time in Contact Lens Users
NA
Recruiting
30 participants
Started: Jan 26, 2022 · Completed: Dec 31, 2023
2 conditions
2 sponsors
1 location
NCT06806813
Italian Anderson Fabry Disease Cardiovascular Registry
N/A
Recruiting
800 participants
Started: Jan 26, 2022 · Completed: Dec 31, 2031
1 condition
1 sponsor
54 locations
NCT04845828
Randomized Comparison Between Sentinel Lymph Node Biopsy and Lymph Node Dissection in Early Stage Endometrial Cancer
NA
Recruiting
810 participants
Started: Jan 26, 2022 · Completed: Dec 1, 2029
1 condition
1 sponsor
1 location
NCT06760260
Evaluation of the Safety and Efficacy of Human CI-135 (FLT3) Targeted CAR-T Cells Injection for Subjects with Relapsed/Refractory Acute Myeloid Leukemia
EARLY_PHASE1
Recruiting
7 participants
Started: Jan 26, 2022 · Completed: Dec 31, 2026
1 condition
2 sponsors
1 location
NCT04919382
Temozolomide and Atezolizumab as Second or Third Line for the Treatment of Metastatic or Recurrent Small Cell Lung Cancer
PHASE2
Recruiting
56 participants
Started: Jan 26, 2022 · Completed: Dec 31, 2026
6 conditions
2 sponsors
5 locations
NCT06325098
Implementation of a Diagnostic Workflow for Personalized Diagnosis of Nephrotic Syndrome
NA
Recruiting
150 participants
Started: Jan 26, 2022 · Completed: Jun 30, 2026
1 condition
1 sponsor
1 location
NCT05202210
Constitution of a Biological Collection to Study the Pathophysiology in Noonan Syndrome
N/A
Recruiting
100 participants
Started: Jan 26, 2022 · Completed: Jan 26, 2032
1 condition
1 sponsor
1 location
NCT05334823
A Study of pCAR-19B in the Treatment of CD19-positive Relapsed/Refractory B-ALL in Children and Adolescents
PHASE2
Recruiting
100 participants
Started: Jan 26, 2022 · Completed: Jul 1, 2025
3 conditions
1 sponsor
10 locations
Previous
1
More pages
1804
1805
1806
1807
1808
1809
1810
More pages
2369
Next